FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

OncoCalendar

« All Events

  • This event has passed.

EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary sAML

Apr 25 • 8:00 AM - Apr 26 • 5:00 PM
EHA-SWG Scientific Meeting

EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary AMLs will be held April 25-26, 2025 at Berlin, Germany.

The EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias (sAML) will focus on therapy-related AML and AML evolving from previous myeloid diseases, such as MDS or MFS/MPN. Key topics will include clonal hematopoiesis, clonal evolution mechanisms, and special clinical situations.

The program will cover pathogenetic mechanisms, including susceptibility factors like molecular lesions, the bone marrow microenvironment, and the impact of drugs. Special topics include sAML following childhood malignancies, gene therapy, CAR-T cell therapy, and AML of donor origin in allogeneic stem cell transplantation. The meeting will feature leading experts in sAML molecular characterization, disease diagnosis, management, and treatment. The event will be chaired by K. Döhner, P. Vyas, and M.T. Voso.

Registration is open.

Details

Start:
Apr 25 • 8:00 AM
End:
Apr 26 • 5:00 PM
Website:
https://ehaweb.org/meetings/eha-swg-scientific-meeting-on-secondary-aml/?utm_source=social_media&utm_campaign=SWG_sAML2025&utm_content=registrationopen&utm_medium=caption

Organizer

European Hematology Association
View Organizer Website

Venue

Berlin
Berlin, Germany + Google Map